Edgar Tracker

IBO IMPACT BIOMEDICAL INC.

NYSE · CIK 1834105 · Pharmaceutical Preparations

SEC company page

Public articles

IBO · DEFM14A

Filing note · DEFM14A · filed 2026-10-27

Impact BioMedical: Zoar Labs Takes Control with 93.32% Stake Impact BioMedical's recent DEFM14A filing outlines a transformative transaction that would see Zoar Labs taking a comm…

Recent filings

–

Form Filed Title Accession
DEFM14A2026-10-27DEFM14A Article0001493152-26-048594
8-K2026-10-095.03 Amendments to Articles of Incorporation or Bylaws · 9.01 Financial Statements and Exhibits0001493152-26-046572
4252026-09-174250001493152-26-042978
8-K2026-09-177.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001493152-26-042975
4252026-09-154250001493152-26-042640
8-K2026-09-157.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001493152-26-042635
10-Q2026-08-0710-Q0001493152-26-036601
10-Q2026-05-1210-Q0001493152-26-022512
S-8 POS2026-04-22S-8 POS0001493152-26-018572
S-8 POS2026-04-06S-8 POS0001493152-26-015316
10-K2026-03-1110-K0001493152-26-009711
8-K2026-03-041.01 Entry into a Material Definitive Agreement · 9.01 Financial Statements and Exhibits0001493152-26-008879
DEF 14C2025-12-30DEF 14C0001493152-25-029621
PRE 14C2025-12-11PRE 14C0001493152-25-027284
10-Q2025-11-0710-Q0001493152-25-021286
8-K2025-11-065.07 Submission of Matters to a Vote of Security Holders0001493152-25-021066
8-K2025-10-278.01 Other Events0001493152-25-019734
DEF 14A2025-09-22DEF 14A0001493152-25-014484
DEF 14C2025-09-09DEF 14C0001641172-25-026976
PRE 14C2025-08-25PRE 14C0001641172-25-025413